Form 4 for HROW HARROW, INC.
Accepted 2026-08-17 17:47:37 ET · period of report 2026-08-14 · accession 0001493152-26-038807 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-08-17 17:47 | 2026-08-14 | HROW | Shojaei Amir | CSO | M - OptEx | $35.96 | +11.2K | 11.2K | New | +$404.6K |
| D | 2026-08-17 17:47 | 2026-08-14 | HROW | Shojaei Amir | CSO | S - Sale+OE | $40.00 | -11.2K | 0 | -100% | -$450.0K |
| D | 2026-08-17 17:47 | 2026-08-14 | HROW | Shojaei Amir | CSO | M - OptEx | $35.96 | -11.2K | 18.8K | -38% | -$404.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-14 | M | A | 11,250 | $35.96 | 11,250 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-14 | S | D | 11,250 | $40.00 | 0 | D | — | — | (F1) The sale reported in this Form 4 was effected as part of a broker-assisted same-day sale transaction in connection with the option exercise reported herein to fund the aggregate exercise price and related transaction costs. The Reporting Person did not retain any shares acquired upon exercise. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-08-14 | M | D | 11,250 | $35.96 | 18,750 | D | $35.96 · — to 2035-01-06 | 11,250 Common Stock | (F2) The option was granted on January 6, 2025. The shares subject to the option vest according to the following schedule: 25% of the shares vested at the one-year anniversary of the date of grant, and the remaining shares vest over the next three years in 12 equal quarterly installments until fully vested and exercisable on January 6, 2029. (F1) The sale reported in this Form 4 was effected as part of a broker-assisted same-day sale transaction in connection with the option exercise reported herein to fund the aggregate exercise price and related transaction costs. The Reporting Person did not retain any shares acquired upon exercise. |